Ofirmev and Metoclopramide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ofirmev (acetaminophen) and Metoclopramide (metoclopramide hydrochloride). Common drug interactions include pancreatitis acute among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ofirmev and Metoclopramide. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Ofirmev?

Ofirmev has active ingredients of acetaminophen. eHealthMe is studying from 817 Ofirmev users. Check the latest studies of Ofirmev.

What is Metoclopramide?

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 81,263 Metoclopramide users. Check the latest studies of Metoclopramide.



On Jul, 17, 2026

23 people who take Ofirmev and Metoclopramide together, and have interactions are studied.

Ofirmev and Metoclopramide drug interactions.

What are the common drug interactions of Ofirmev and Metoclopramide, by gender? *:

female:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Burning sensation
  3. Erythema (redness of the skin)
  4. Pruritus (severe itching of the skin)
  5. Skin hyperpigmentation (disorders affect the colour of your skin)
  6. Skin lesion
  7. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Ankle fracture

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Drug ineffective
  4. Dystonia (abnormal muscle tone)
  5. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  6. Headache (pain in head)
  7. Leukocytosis (increased white blood cells)
  8. Post-traumatic neck syndrome
  9. Psychomotor hyperactivity (feelings of extreme restlessness)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Ofirmev and Metoclopramide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anxiety
  2. Discomfort
  3. Drug ineffective
  4. Dystonia (abnormal muscle tone)
  5. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  6. Headache (pain in head)
  7. Leukocytosis (increased white blood cells)
  8. Post-traumatic neck syndrome
  9. Psychomotor hyperactivity (feelings of extreme restlessness)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

20-29:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Premature delivery

30-39:

  1. Chest discomfort
  2. Chest pain
  3. Electrocardiogram t wave amplitude decreased
  4. Electrocardiogram t wave inversion
  5. Hypotension (abnormally low blood pressure)

40-49:

  1. Burning sensation
  2. Erythema (redness of the skin)
  3. Pruritus (severe itching of the skin)
  4. Skin hyperpigmentation (disorders affect the colour of your skin)
  5. Skin lesion
  6. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

50-59:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Pancreatitis (inflammation of pancreas)
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Hypotension (abnormally low blood pressure)
  4. Pain
  5. Anaemia (lack of blood)
  6. Embolic stroke (stroke due to obstruction due to an embolus)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  9. Acidosis (build-up of carbon dioxide in the blood)
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Pain: 4 people, 17.39%
  2. Nausea And Vomiting: 4 people, 17.39%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.04%
  4. Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 8.70%
  5. Headache (pain in head): 2 people, 8.70%
  6. Constipation: 2 people, 8.70%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.70%
  8. Dehydration (dryness resulting from the removal of water): 2 people, 8.70%
  9. Drug Eruption (adverse drug reaction of the skin): 2 people, 8.70%
  10. Essential Hypertension (primary hypertension): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ofirmev and Metoclopramide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ofirmev and Metoclopramide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ofirmev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metoclopramide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ofirmev and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metoclopramide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen and metoclopramide hydrochloride (the active ingredients of Ofirmev and Metoclopramide, respectively), and Ofirmev and Metoclopramide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: